ATPergic signalling during seizures and epilepsy

Neuropharmacology

Volumn 104, Issue , 2016, Pages 140-153

  Engel, Tobias ^a   Alves, Mariana ^a   Sheedy, Caroline ^a   Henshall, David C ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

Author keywords

ATP; Epilepsy; P2 purinergic receptors; Seizures; Status epilepticus

Indexed keywords

ADENOSINE TRIPHOSPHATE; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2X2 RECEPTOR; PURINERGIC P2X3 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC P2X5 RECEPTOR; PURINERGIC P2X6 RECEPTOR; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y1 RECEPTOR; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y12 RECEPTOR; PURINERGIC P2Y13 RECEPTOR; PURINERGIC P2Y14 RECEPTOR; PURINERGIC P2Y2 RECEPTOR; PURINERGIC P2Y4 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; PURINERGIC RECEPTOR; UNCLASSIFIED DRUG; PURINERGIC P2 RECEPTOR; PURINERGIC P2 RECEPTOR ANTAGONIST;

ASTROCYTE; BRAIN CORTEX; EPILEPSY; EPILEPTIC STATE; EPILEPTOGENESIS; HIPPOCAMPUS; HUMAN; MICROGLIA; NERVE CELL EXCITABILITY; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; SEIZURES; STATUS EPILEPTICUS;

ADENOSINE TRIPHOSPHATE; ANIMALS; EPILEPSY; HUMANS; PURINERGIC P2 RECEPTOR ANTAGONISTS; RECEPTORS, PURINERGIC P2; SEIZURES; SIGNAL TRANSDUCTION; STATUS EPILEPTICUS;

EID: 84947319090     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2015.11.001     Document Type: Review

References (185)

1. C. Agresti, and et al. Metabotropic P2 receptor activation regulates oligodendrocyte progenitor migration and development Glia 50 2 2005 132 144
2. A.V. Alberto, and et al. Is pannexin the pore associated with the P2X7 receptor? Naunyn Schmiedeb. Arch. Pharmacol. 386 9 2013 775 787
3. S. Alloisio, and et al. Functional evidence for presynaptic P2X7 receptors in adult rat cerebrocortical nerve terminals FEBS Lett. 582 28 2008 3948 3953
4. S. Amadio, and et al. P2 receptor modulation and cytotoxic function in cultured CNS neurons Neuropharmacology 42 4 2002 489 501
5. S. Amadio, and et al. Oligodendrocytes express P2Y12 metabotropic receptor in adult rat brain Neuroscience 141 3 2006 1171 1180
6. R.D. Ando, and B. Sperlagh The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain Brain Res. Bull. 93 2013 80 85
7. J.N. Armstrong, and et al. Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase J. Neurosci. 22 14 2002 5938 5945
8. E. Aronica, and J.A. Gorter Gene expression profile in temporal lobe epilepsy Neuroscientist 13 2 2007 100 108
9. E. Avignone, and et al. Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling J. Neurosci. 28 37 2008 9133 9144
10. S. Balosso, and et al. A novel non-transcriptional pathway mediates the proconvulsive effects of interleukin-1beta Brain 131 Pt 12 2008 3256 3265
11. P. Bedner, and et al. Astrocyte uncoupling as a cause of human temporal lobe epilepsy Brain 138 Pt 5 2015 1208 1222
12. J.P. Betjemann, and et al. Trends in status epilepticus-related hospitalizations and mortality: redefined in US practice over time JAMA Neurol. 72 6 2015 650 655
13. J.P. Betjemann, and D.H. Lowenstein Status epilepticus in adults Lancet Neurol. 14 6 2015 615 624
14. A. Bhattacharya, and et al. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567 Br. J. Pharmacol. 170 3 2013 624 640
15. M. Bialer, and et al. Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI) Epilepsy Res. 103 1 2013 2 30
16. F. Bianco, and et al. Pathophysiological roles of extracellular nucleotides in glial cells: differential expression of purinergic receptors in resting and activated microglia Brain Res. Brain Res. Rev. 48 2 2005 144 156
17. D.K. Binder, and C. Steinhauser Functional changes in astroglial cells in epilepsy Glia 54 5 2006 358 368
18. W. Bintig, and et al. Purine receptors and Ca(2+) signalling in the human blood-brain barrier endothelial cell line hCMEC/D3 Purinergic Signal 8 1 2012 71 80
19. D. Boison Adenosine dysfunction and adenosine kinase in epileptogenesis Open Neurosci. J. 4 2010 93 101
20. D. Boison Role of adenosine in status epilepticus: a potential new target? Epilepsia 54 Suppl. 6 2013 20 22
21. D. Boison Adenosine and seizure termination: endogenous mechanisms Epilepsy Curr. 13 1 2013 35 37
22. D. Boison Adenosinergic signaling in epilepsy Neuropharmacology 104 2015 Sep 1 131 139 pii: S0028-3908(15)30091-5 http://dx.doi.org/10.1016/j.neuropharm.2015.08.046
23. C.D. Bonan, and et al. Changes in synaptosomal ectonucleotidase activities in two rat models of temporal lobe epilepsy Epilepsy Res. 39 3 2000 229 238
24. D.N. Bowser, and B.S. Khakh ATP excites interneurons and astrocytes to increase synaptic inhibition in neuronal networks J. Neurosci. 24 39 2004 8606 8620
25. G. Burnstock Physiology and pathophysiology of purinergic neurotransmission Physiol. Rev. 87 2 2007 659-797
26. G. Burnstock Purinergic signalling and disorders of the central nervous system Nat. Rev. Drug Discov. 7 7 2008 575 590
27. G. Burnstock Introduction to purinergic signalling in the brain Adv. Exp. Med. Biol. 986 2013 1 12
28. G. Burnstock An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration Neuropharmacology 15 2015 S0028 S3908
29. G. Burnstock, and A. Verkhratsky Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death Cell Death Dis. 1 2010 e9
30. G. Burnstock, B.B. Fredholm, and A. Verkhratsky Adenosine and ATP receptors in the brain Curr. Top. Med. Chem. 11 8 2011 973 1011
31. R.C. Campos, and et al. Pharmacological blockage and P2X7 deletion hinder aversive memories: reversion in an enriched environment Neuroscience 280 2014 220 230
32. L.M. Carrasquero, and et al. P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes J. Neurochem. 110 3 2009 879 889
33. M. Cattaneo P2Y12 receptors: structure and function J. Thromb. Haemost. 13 Suppl. 1 2015 S10 S16
34. Y. Chakfe, and et al. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels J. Neurosci. 22 8 2002 3061 3069
35. J.K. Chambers, and et al. A G protein-coupled receptor for UDP-glucose J. Biol. Chem. 275 15 2000 10767 10771
36. B.S. Chang, and D.H. Lowenstein Epilepsy N. Engl. J. Med. 349 13 2003 1257 1266
37. J.W. Chen, and C.G. Wasterlain Status epilepticus: pathophysiology and management in adults Lancet Neurol. 5 3 2006 246 256
38. J. Choi, and et al. Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state Glia 59 2 2011 219 230
39. G. Collo, and et al. Cloning of P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels J. Neurosci. 16 8 1996 2495 2507
40. D. Communi, and et al. Identification of a novel human ADP receptor coupled to G(i) J. Biol. Chem. 276 44 2001 41479 41485
41. D. Communi, B. Robaye, and J.M. Boeynaems Pharmacological characterization of the human P2Y11 receptor Br. J. Pharmacol. 128 6 1999 1199 1206
42. M. Crompton The mitochondrial permeability transition pore and its role in cell death Biochem. J. 341 Pt 2 1999 233 249
43. C. Csolle, and et al. P2Y receptor mediated inhibitory modulation of noradrenaline release in response to electrical field stimulation and ischemic conditions in superfused rat hippocampus slices J. Neurochem. 106 1 2008 347 360
44. G. Curia, and et al. The pilocarpine model of temporal lobe epilepsy J. Neurosci. Methods 172 2 2008 143 157
45. I. D'Alimonte, and et al. Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease Eur. J. Neurosci. 30 6 2009 1023 1035
46. N. Dale, and B.G. Frenguelli Release of adenosine and ATP during ischemia and epilepsy Curr. Neuropharmacol. 7 3 2009 160 179
47. A. Del Puerto, F. Wandosell, and J.J. Garrido Neuronal and glial purinergic receptors functions in neuron development and brain disease Front. Cell Neurosci. 7 2013 197
48. R.J. DeLorenzo, and et al. Epidemiology of status epilepticus J. Clin. Neurophysiol. 12 4 1995 316 325
49. S.A. Deuchars, and et al. Neuronal P2X7 receptors are targeted to presynaptic terminals in the central and peripheral nervous systems J. Neurosci. 21 18 2001 7143 7152
50. M. Diaz-Hernandez, and et al. Altered P2X7-receptor level and function in mouse models of Huntington's disease and therapeutic efficacy of antagonist administration FASEB J. 23 6 2009 1893 1906
51. J.I. Diaz-Hernandez, and et al. In vivo P2X7 inhibition reduces amyloid plaques in Alzheimer's disease through GSK3beta and secretases Neurobiol. Aging 33 8 2012 1816 1828
52. S.J. Dixon, and et al. Activation of P2 nucleotide receptors stimulates acid efflux from astrocytes Glia 47 4 2004 367 376
53. A. Dobolyi, and et al. Uridine function in the central nervous system Curr. Top. Med. Chem. 11 8 2011 1058 1067
54. F. Dona, and et al. Alteration of purinergic P2X4 and P2X7 receptor expression in rats with temporal-lobe epilepsy induced by pilocarpine Epilepsy Res. 83 2-3 2009 157 167
55. R. Donato, and et al. GABA release by basket cells onto Purkinje cells, in rat cerebellar slices, is directly controlled by presynaptic purinergic receptors, modulating Ca2+ influx Cell Calcium 44 6 2008 521 532
56. S. Duan, and et al. P2X7 receptor-mediated release of excitatory amino acids from astrocytes J. Neurosci. 23 4 2003 1320 1328
57. M. El Yacoubi, and et al. Adenosine A2A receptor deficient mice are partially resistant to limbic seizures Naunyn Schmiedeb. Arch. Pharmacol. 380 3 2009 223 232
58. H.C. Emsley, and et al. Variations in inflammation-related genes may be associated with childhood febrile seizure susceptibility Seizure 23 6 2014 457 461
59. T. Engel, and et al. P2X7 receptor in epilepsy; role in pathophysiology and potential targeting for seizure control Int. J. Physiol. Pathophysiol. Pharmacol. 4 4 2012 174 187
60. T. Engel, and et al. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice FASEB J. 26 4 2012 1616 1628
61. U.B. Eyo, and et al. Neuronal hyperactivity recruits microglial processes via neuronal NMDA receptors and microglial P2Y12 receptors after status epilepticus J. Neurosci. 34 32 2014 10528 10540
62. S.R. Fam, C.J. Gallagher, and M.W. Salter P2Y(1) purinoceptor-mediated Ca(2+) signaling and Ca(2+) wave propagation in dorsal spinal cord astrocytes J. Neurosci. 20 8 2000 2800 2808
63. D.E. Fedele, and et al. Adenosine A1 receptors are crucial in keeping an epileptic focus localized Exp. Neurol. 200 1 2006 184 190
64. N. Ferri, A. Corsini, and S. Bellosta Pharmacology of the new P2Y12 receptor inhibitors: insights on pharmacokinetic and pharmacodynamic properties Drugs 73 15 2013 1681 1709
65. D.M. Ficker, and et al. Population-based study of the incidence of sudden unexplained death in epilepsy Neurology 51 5 1998 1270 1274
66. R.D. Fields, and G. Burnstock Purinergic signalling in neuron-glia interactions Nat. Rev. Neurosci. 7 6 2006 423 436
67. W. Fischer, and et al. Increase of intracellular Ca2+ by P2X and P2Y receptor-subtypes in cultured cortical astroglia of the rat Neuroscience 160 4 2009 767 783
68. R.S. Fisher, K.S. Eggleston, and C.W. Wright Vagus nerve stimulation magnet activation for seizures: a critical review Acta Neurol. Scand. 131 1 2015 1 8
69. H. Franke, and et al. Involvement of P2X and P2Y receptors in microglial activation in vivo Purinergic Signal 3 4 2007 435 445
70. H. Franke, U. Krugel, and P. Illes P2 receptors and neuronal injury Pflugers Arch. 452 5 2006 622 644
71. M. Fumagalli, and et al. Nucleotide-mediated calcium signaling in rat cortical astrocytes: role of P2X and P2Y receptors Glia 43 3 2003 218 303
72. T. Glaser, and et al. Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration Purinergic Signal 8 3 2012 523 537
73. M. Glass, and et al. Loss of A1 adenosine receptors in human temporal lobe epilepsy Brain Res. 710 1-2 1996 56 68
74. J. Goncalves, and G. Queiroz Presynaptic adenosine and P2Y receptors Handb. Exp. Pharmacol. 184 2008 339 372
75. C. Hamani, and L.E. Mello Status epilepticus induced by pilocarpine and picrotoxin Epilepsy Res. 28 1 1997 73 82
76. T.D. Hassinger, and et al. An extracellular signaling component in propagation of astrocytic calcium waves Proc. Natl. Acad. Sci. U. S. A. 93 23 1996 13268 13273
77. A. Heinrich, and et al. Modulation of neurotransmitter release by P2X and P2Y receptors in the rat spinal cord Neuropharmacology 54 2 2008 375 386
78. D.C. Henshall, and T. Engel P2X purinoceptors as a link between hyperexcitability and neuroinflammation in status epilepticus Epilepsy Behav. 49 2015 8 12
79. D.C. Henshall, and et al. P2X receptors as targets for the treatment of status epilepticus Front. Cell Neurosci. 7 2013 237
80. C. Hervas, R. Perez-Sen, and M.T. Miras-Portugal Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells J. Neurosci. Res. 73 3 2003 384 399
81. Y.A. Huang, and et al. Knocking out P2X receptors reduces transmitter secretion in taste buds J. Neurosci. 31 38 2011 13654 13661
82. M. Idzko, D. Ferrari, and H.K. Eltzschig Nucleotide signalling during inflammation Nature 509 7500 2014 310 317
83. R. Jabs, and et al. Lack of P2X receptor mediated currents in astrocytes and GluR type glial cells of the hippocampal CA1 region Glia 55 16 2007 1648 1655
84. M.J. Jackson, and D. Turkington Depression and anxiety in epilepsy J. Neurol. Neurosurg. Psychiatry 76 Suppl. 1 2005 i45 47
85. P.F. Jacob, and et al. P2Y1 receptor inhibits GABA transport through a calcium signalling-dependent mechanism in rat cortical astrocytes Glia 62 8 2014 1211 1226
86. K.A. Jacobson, and J.M. Boeynaems P2Y nucleotide receptors: promise of therapeutic applications Drug Discov. Today 15 13-14 2010 570 578
87. J.G. Jefferys Hippocampal sclerosis and temporal lobe epilepsy: cause or consequence? Brain 122 Pt 6 1999 1007 1008
88. S. Jenssen, E.J. Gracely, and M.R. Sperling How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit Epilepsia 47 9 2006 1499 1503
89. A. Jimenez-Pacheco, and et al. Increased neocortical expression of the P2X7 receptor after status epilepticus and anticonvulsant effect of P2X7 receptor antagonist A-438079 Epilepsia 54 9 2013 1551 1561
90. T.C. Kang, and et al. P2X2 and P2X4 receptor expression is regulated by a GABA(A) receptor-mediated mechanism in the gerbil hippocampus Brain Res. Mol. Brain Res. 116 1-2 2003 168 175
91. B.S. Khakh, and et al. ATP modulation of excitatory synapses onto interneurons J. Neurosci. 23 19 2003 7426 7437
92. B.S. Khakh, and R.A. North P2X receptors as cell-surface ATP sensors in health and disease Nature 442 7102 2006 527 532
93. J.E. Kim, and et al. Blockade of P2X receptor prevents astroglial death in the dentate gyrus following pilocarpine-induced status epilepticus Neurol. Res. 31 9 2009 982 988
94. J.E. Kim, and et al. P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus J. Neuroinflammation 7 2010 65
95. J.E. Kim, and T.C. Kang The P2X7 receptor-pannexin-1 complex decreases muscarinic acetylcholine receptor-mediated seizure susceptibility in mice J. Clin. Investig. 121 5 2011 2037 2047
96. J.E. Kim, H.J. Ryu, and T.C. Kang P2X7 receptor activation ameliorates CA3 neuronal damage via a tumor necrosis factor-alpha-mediated pathway in the rat hippocampus following status epilepticus J. Neuroinflammation 8 2011 62
97. L.J.S. Knutsen, and T. Murray Adenosine and ATP in epilepsy K.A. Jakobson, M.F. Jarvis, Purinergic Approaches in Experimental Therapeutics 1997 432 447
98. L. Koles, and et al. P2 receptor signaling in neurons and glial cells of the central nervous system Adv. Pharmacol. 61 2011 441 493
99. Z. Kovacs, and et al. Uridine modulates neuronal activity and inhibits spike-wave discharges of absence epileptic Long Evans and Wistar Albino Glaxo/Rijswijk rats Brain Res. Bull. 97 2013 16 23
100. M. Kukley, and et al. Distribution of P2X receptors on astrocytes in juvenile rat hippocampus Glia 36 1 2001 11 21
101. M.B. Kulick, and I. von Kugelgen P2Y-receptors mediating an inhibition of the evoked entry of calcium through N-type calcium channels at neuronal processes J. Pharmacol. Exp. Ther. 303 2 2002 520 526
102. U. Lalo, and et al. P2X1 and P2X5 subunits form the functional P2X receptor in mouse cortical astrocytes J. Neurosci. 28 21 2008 5473 5480
103. E.R. Lazarowski, and et al. Molecular mechanisms of purine and pyrimidine nucleotide release Adv. Pharmacol. 61 2011 221 261
104. S.G. Lechner, and et al. Autoinhibition of transmitter release from PC12 cells and sympathetic neurons through a P2Y receptor-mediated inhibition of voltage-gated Ca2+ channels Eur. J. Neurosci. 20 11 2004 2917 2928
105. M. Levesque, and M. Avoli The kainic acid model of temporal lobe epilepsy Neurosci. Biobehav. Rev. 37 10 Pt 2 2013 2887 2899
106. T. Li, and et al. Adenosine dysfunction in astrogliosis: cause for seizure generation? Neuron Glia Biol. 3 4 2007 353 366
107. G. Logroscino, and et al. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus Epilepsia 42 8 2001 1031 1035
108. J. Lopatar, N. Dale, and B.G. Frenguelli Minor contribution of ATP P2 receptors to electrically-evoked electrographic seizure activity in hippocampal slices: evidence from purine biosensors and P2 receptor agonists and antagonists Neuropharmacology 61 1-2 2011 25 34
109. B. Lord, and et al. Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432 J. Pharmacol. Exp. Ther. 351 3 2014 628 641
110. W. Loscher Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy Prog. Neurobiol. 54 6 1998 721 741
111. W. Loscher Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs Seizure 20 5 2011 359 368
112. D.H. Lowenstein Treatment options for status epilepticus Curr. Opin. Pharmacol. 5 3 2005 334 339
113. S.A. Malin, and D.C. Molliver Gi- and Gq-coupled ADP (P2Y) receptors act in opposition to modulate nociceptive signaling and inflammatory pain behavior Mol. Pain 6 2010 21
114. N. Marchi, and et al. Antagonism of peripheral inflammation reduces the severity of status epilepticus Neurobiol. Dis. 33 2 2009 171 181
115. M. Marcoli, and et al. P2X7 pre-synaptic receptors in adult rat cerebrocortical nerve terminals: a role in ATP-induced glutamate release J. Neurochem. 105 6 2008 2330 2342
116. M. Maroso, and et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures Nat. Med. 16 4 2010 413 419
117. S.A. Masino, M. Kawamura Jr., and D.N. Ruskin Adenosine receptors and epilepsy: current evidence and future potential Int. Rev. Neurobiol. 119 2014 233 255
118. B.S. Meldrum First Alfred Meyer Memorial Lecture. Epileptic brain damage: a consequence and a cause of seizures Neuropathol. Appl. Neurobiol. 23 3 1997 185 201 discussion 201-2
119. G. Mesuret, and et al. P2X7 receptor inhibition interrupts the progression of seizures in immature rats and reduces hippocampal damage CNS Neurosci. Ther. 20 6 2014 556 564
120. M. Monif, G. Burnstock, and D.A. Williams Microglia: proliferation and activation driven by the P2X7 receptor Int. J. Biochem. Cell Biol. 42 11 2010 1753 1756
121. T.D. Montero, and J.A. Orellana Hemichannels: new pathways for gliotransmitter release Neuroscience 286 2015 45 59
122. D.J. Moore, and et al. Expression pattern of human P2Y receptor subtypes: a quantitative reverse transcription-polymerase chain reaction study Biochim. Biophys. Acta 1521 1-3 2001 107 119
123. S.L. Moshe, and et al. Epilepsy: new advances Lancet 2014 884 898 7(385(9971):)
124. G. Mouri, and et al. Unilateral hippocampal CA3-predominant damage and short latency epileptogenesis after intra-amygdala microinjection of kainic acid in mice Brain Res. 1213 2008 140 151
125. N. Naumann, and et al. P-glycoprotein expression increases ATP release in respiratory cystic fibrosis cells J. Cyst. Fibros. 4 3 2005 157 168
126. R.A. Nicholas, and et al. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor Mol. Pharmacol. 50 2 1996 224 229
127. J. Noebels Pathway-driven discovery of epilepsy genes Nat. Neurosci. 18 3 2015 344 350
128. R.A. North Molecular physiology of P2X receptors Physiol. Rev. 82 4 2002 1013 1067
129. R.A. North, and M.F. Jarvis P2X receptors as drug targets Mol. Pharmacol. 83 4 2013 759 769
130. J. Novy, G. Logroscino, and A.O. Rossetti Refractory status epilepticus: a prospective observational study Epilepsia 51 2 2010 251 256
131. P.I. Ortinski, and et al. Selective induction of astrocytic gliosis generates deficits in neuronal inhibition Nat. Neurosci. 13 5 2010 584 591
132. Y. Pankratov, and et al. Vesicular release of ATP at central synapses Pflugers Arch. 452 5 2006 589 597
133. Y. Pankratov, and et al. P2X receptors and synaptic plasticity Neuroscience 158 1 2009 137 148
134. Y.V. Pankratov, U.V. Lalo, and O.A. Krishtal Role for P2X receptors in long-term potentiation J. Neurosci. 22 19 2002 8363 8369
135. L. Papp, E.S. Vizi, and B. Sperlagh Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/- mice Neuroreport 15 15 2004 2387 2391
136. O. Pascual, and et al. Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission Proc. Natl. Acad. Sci. U. S. A. 109 4 2012 E197 E205
137. A. Pitkanen, and K. Lukasiuk Mechanisms of epileptogenesis and potential treatment targets Lancet Neurol. 10 2 2011 173 186
138. A.D. Powell, A.G. Teschemacher, and E.P. Seward P2Y purinoceptors inhibit exocytosis in adrenal chromaffin cells via modulation of voltage-operated calcium channels J. Neurosci. 20 2 2000 606 616
139. M. Pugliatti, and et al. Estimating the cost of epilepsy in Europe: a review with economic modeling Epilepsia 48 12 2007 2224 2233
140. G. Queiroz, C. Talaia, and J. Goncalves ATP modulates noradrenaline release by activation of inhibitory P2Y receptors and facilitatory P2X receptors in the rat vas deferens J. Pharmacol. Exp. Ther. 307 2 2003 809 815
141. V. Ralevic, and W.R. Dunn Purinergic transmission in blood vessels Auton. Neurosci. 191 2015 48 66
142. P.M. Rappold, E. Lynd-Balta, and S.A. Joseph P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain Brain Res. 1089 1 2006 171 178
143. T. Ravizza, and et al. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy Neurobiol. Dis. 29 1 2008 142 160
144. S. Robel, and et al. Reactive astrogliosis causes the development of spontaneous seizures J. Neurosci. 35 8 2015 3330 3345
145. R.J. Rodrigues, and et al. Dual presynaptic control by ATP of glutamate release via facilitatory P2X1, P2X2/3, and P2X3 and inhibitory P2Y1, P2Y2, and/or P2Y4 receptors in the rat hippocampus J. Neurosci. 25 27 2005 6286 6295
146. R.J. Rodrigues, A.R. Tome, and R.A. Cunha ATP as a multi-target danger signal in the brain Front. Neurosci. 9 2015 148
147. F.M. Ross, M.J. Brodie, and T.W. Stone Modulation by adenine nucleotides of epileptiform activity in the CA3 region of rat hippocampal slices Br. J. Pharmacol. 123 1 1998 71 80
148. T.L. Roth, and et al. Transcranial amelioration of inflammation and cell death after brain injury Nature 505 7482 2014 223 228
149. K. Sawada, and et al. Identification of a vesicular nucleotide transporter Proc. Natl. Acad. Sci. U. S. A. 105 15 2008 5683 5686
150. M.R. Schetinger, and et al. NTPDase and 5′-nucleotidase activities in physiological and disease conditions: new perspectives for human health Biofactors 31 2 2007 77 98
151. A. Sebastian-Serrano, and et al. Tissue-nonspecific alkaline phosphatase regulates purinergic transmission in the central nervous system during development and disease Comput. Struct. Biotechnol. J. 13 2015 95 100
152. J.A. Sim, and et al. Altered hippocampal synaptic potentiation in P2X4 knock-out mice J. Neurosci. 26 35 2006 9006 9009
153. J. Simon, and et al. Characterization and channel coupling of the P2Y(12) nucleotide receptor of brain capillary endothelial cells J. Biol. Chem. 277 35 2002 31390 31400
154. S.D. Skaper, P. Debetto, and P. Giusti The P2X7 purinergic receptor: from physiology to neurological disorders FASEB J. 24 2 2010 337 345
155. M. Solle, and et al. Altered cytokine production in mice lacking P2X(7) receptors J. Biol. Chem. 276 1 2001 125 132
156. N. Soni, and et al. Effect of GLT-1 modulator and P2X7 antagonists alone and in combination in the kindling model of epilepsy in rats Epilepsy Behav. 48 2015 4 14
157. G. Sperk Kainic acid seizures in the rat Prog. Neurobiol. 42 1 1994 1 32
158. B. Sperlagh, and et al. Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus J. Neurochem. 81 6 2002 1196 1211
159. B. Sperlagh, and et al. P2X7 receptors in the nervous system Prog. Neurobiol. 78 6 2006 327 346
160. B. Sperlagh, and et al. The role of purinergic signaling in depressive disorders Neuropsychopharmacol. Hung 14 4 2012 231 238
161. B. Sperlagh, and P. Illes P2X7 receptor: an emerging target in central nervous system diseases Trends Pharmacol. Sci. 35 10 2014 537 547
162. B. Sperlagh, A. Heinrich, and C. Csolle P2 receptor-mediated modulation of neurotransmitter release-an update Purinergic Signal 3 4 2007 269 284
163. S. Sukigara, and et al. Expression of astrocyte-related receptors in cortical dysplasia with intractable epilepsy J. Neuropathol. Exp. Neurol. 73 8 2014 798 806
164. A. Surprenant, and et al. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7) Science 272 5262 1996 735 738
165. A. Surprenant, and R.A. North Signaling at purinergic P2X receptors Annu. Rev. Physiol. 71 2009 333 359
166. J. Takasaki, and et al. Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor Mol. Pharmacol. 60 3 2001 432 439
167. L. Ulmann, and et al. Involvement of P2X4 receptors in hippocampal microglial activation after status epilepticus Glia 61 8 2013 1306 1319
168. I.F. Uludag, and et al. IL-1beta, IL-6 and IL1Ra levels in temporal lobe epilepsy Seizure 26 2015 22 25
169. A. Verkhratsky, O.A. Krishtal, and G. Burnstock Purinoceptors on neuroglia Mol. Neurobiol. 39 3 2009 190 208
170. A. Vezzani Epilepsy and inflammation in the brain: overview and pathophysiology Epilepsy Curr. 14 1 Suppl. l 2014 3 7
171. A. Vezzani, and et al. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice Proc. Natl. Acad. Sci. U. S. A. 97 21 2000 11534 11539
172. A. Vezzani, and et al. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis Epilepsia 43 Suppl. 5 2002 30 35
173. G.L. Waldo, and T.K. Harden Agonist binding and Gq-stimulating activities of the purified human P2Y1 receptor Mol. Pharmacol. 65 2 2004 426 436
174. C.M. Wallace How to be the perfect nurse Nurs. Mirror Midwives J. 130 15 1970 19
175. T.E. Webb, and et al. The P2Y purinoceptor in rat brain microvascular endothelial cells couple to inhibition of adenylate cyclase Br. J. Pharmacol. 119 7 1996 1385 1392
176. G.A. Weisman, and et al. P2Y receptors in the mammalian nervous system: pharmacology, ligands and therapeutic potential CNS Neurol. Disord. Drug Targets 11 6 2012 722 738
177. S. Wiebe, and et al. A randomized, controlled trial of surgery for temporal-lobe epilepsy N. Engl. J. Med. 345 5 2001 311 318
178. S. Wiebe, and N. Jette Pharmacoresistance and the role of surgery in difficult to treat epilepsy Nat. Rev. Neurol. 8 12 2012 669 677
179. A. Wieraszko, and T.N. Seyfried Increased amount of extracellular ATP in stimulated hippocampal slices of seizure prone mice Neurosci. Lett. 106 3 1989 287 293
180. A. Wieraszko, G. Goldsmith, and T.N. Seyfried Stimulation-dependent release of adenosine triphosphate from hippocampal slices Brain Res. 485 2 1989 244 250
181. P.H. Wu, and J.W. Phillis Distribution and release of adenosine triphosphate in rat brain Neurochem. Res. 3 5 1978 563 571
182. Z. Xiang, and G. Burnstock Expression of P2X receptors on rat microglial cells during early development Glia 52 2 2005 119 126
183. A.E. Ziemann, and et al. Seizure termination by acidosis depends on ASIC1a Nat. Neurosci. 11 7 2008 816 822
184. H. Zimmermann Biochemistry, localization and functional roles of ecto-nucleotidases in the nervous system Prog. Neurobiol. 49 6 1996 589 618
185. H. Zimmermann, and N. Braun Ecto-nucleotidases-molecular structures, catalytic properties, and functional roles in the nervous system Prog. Brain Res. 120 1999 371 385